JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2851
CALL
Caterpillar
CAT
$397B
| $2.07M | ﹤0.01% |
19,300
-2,730
| -12% | -$277K |
2016 Q4
2 quarters
|
|
2852
Smith & Nephew
SNN
$11.2B
| $2.07M | ﹤0.01% |
59,414
-159,626
| -73% | -$5.4M |
2014 Q2
12 quarters
|
|
|
GEN
2853
DELISTED
Genesis Healthcare, Inc.
GEN
| $2.07M | ﹤0.01% |
1,188,100
+161,931
| +16% | +$344K |
2016 Q4
2 quarters
|
|
|
CVSA
2854
Covista Inc
CVSA
$4.32B
| $2.06M | ﹤0.01% |
54,396
-236,842
| -81% | -$8.83M |
2013 Q2
16 quarters
|
|
2855
Oxford Square Capital
OXSQ
$137M
| $2.06M | ﹤0.01% |
324,903
-31,733
| -9% | -$227K |
2015 Q4
6 quarters
|
|
2856
Constellium
CSTM
$3.46B
| $2.06M | ﹤0.01% |
298,250
+212,921
| +250% | +$1.39M |
2014 Q3
11 quarters
|
|
2857
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.8B
| $2.06M | ﹤0.01% |
19,025
+11,238
| +144% | +$1.2M |
2013 Q3
15 quarters
|
|
2858
Winnebago Industries
WGO
$705M
| $2.06M | ﹤0.01% |
58,751
-28,696
| -33% | -$804K |
2016 Q1
5 quarters
|
|
|
ZAYO
2859
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $2.06M | ﹤0.01% |
66,517
-503,744
| -88% | -$16.5M |
2014 Q4
10 quarters
|
|
2860
Navios Maritime Partners
NMM
$2.65B
| $2.05M | ﹤0.01% |
85,944
-14,127
| -14% | -$379K |
2013 Q2
16 quarters
|
|
|
ELLI
2861
DELISTED
Ellie Mae Inc
ELLI
| $2.04M | ﹤0.01% |
18,610
+14,667
| +372% | +$1.59M |
2015 Q4
6 quarters
|
|
|
NSH
2862
DELISTED
NuStar GP Holdings LLC
NSH
| $2.04M | ﹤0.01% |
83,613
-3,260
| -4% | -$84.3K |
2013 Q2
16 quarters
|
|
2863
CALL
Nektar Therapeutics
NKTR
$1.36B
| $2.04M | ﹤0.01% |
6,947
| – | – |
2017 Q1
1 quarter
|
|
2864
PUT
NextEra Energy
NEE
$162B
| $2.03M | ﹤0.01% |
58,000
| – | – |
2017 Q1
1 quarter
|
|
2865
PUT
Qualcomm
QCOM
$193B
| $2.03M | ﹤0.01% |
36,800
-221,500
| -86% | -$12.4M |
2017 Q1
1 quarter
|
|
|
TBNK
2866
DELISTED
Territorial Bancorp Inc.
TBNK
| $2.03M | ﹤0.01% |
64,958
-609
| -0.9% | -$18.9K |
2014 Q1
13 quarters
|
|
2867
Citizens & Northern Corp
CZNC
$457M
| $2.02M | ﹤0.01% |
86,864
-15,975
| -16% | -$369K |
2013 Q2
16 quarters
|
|
|
ABMD
2868
DELISTED
Abiomed Inc
ABMD
| $2.02M | ﹤0.01% |
14,094
+680
| +5% | +$91.4K |
2015 Q3
7 quarters
|
|
|
APLP
2869
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
| $2.01M | ﹤0.01% |
134,923
+26,690
| +25% | +$418K |
2013 Q2
16 quarters
|
|
2870
PUT
KBR
KBR
$4.36B
| $2M | ﹤0.01% |
+131,422
| New | +$1.95M |
2017 Q2
0 quarters
|
|
2871
VanEck Junior Gold Miners ETF
GDXJ
$8.36B
| $2M | ﹤0.01% |
59,852
-585,165
| -91% | -$19.5M |
2016 Q2
4 quarters
|
|
|
BPFH
2872
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $1.99M | ﹤0.01% |
129,825
-37,542
| -22% | -$582K |
2013 Q2
16 quarters
|
|
|
BEAT
2873
DELISTED
BioTelemetry, Inc.
BEAT
| $1.99M | ﹤0.01% |
59,591
-27,885
| -32% | -$832K |
2016 Q3
3 quarters
|
|
|
IRBT
2874
DELISTED
iRobot
IRBT
| $1.99M | ﹤0.01% |
23,638
-42,535
| -64% | -$3.67M |
2013 Q2
16 quarters
|
|
2875
HNI Corp
HNI
$3.37B
| $1.98M | ﹤0.01% |
49,780
-120,204
| -71% | -$5.24M |
2013 Q2
16 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.